Xponance’s Praxis Precision Medicines PRAX Stock Holding History

Xponance’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$829K	Buy	2,476 +56	+2%	+$17.7K	0.01%	864
2026 Q1	$780K	Buy	2,420 +656	+37%	+$203K	0.01%	836
2025 Q4	$520K	Buy	+1,764	New	+$328K	﹤0.01%	935

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Xponance's PRAX Position: Q2 2026 in Review

Xponance increased its Praxis Precision Medicines (PRAX) stake by 2.3% in Q2 2026, buying an estimated $17.7K and bringing the position to 2,476 shares worth $829K. The position accounts for 0.01% of the portfolio, ranked #864.

Xponance first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Xponance held 2,476 shares of Praxis Precision Medicines worth $829K as of Q2 2026.
Xponance bought 56 Praxis Precision Medicines shares in Q2 2026, an estimated $17.7K.
Praxis Precision Medicines made up 0.01% of Xponance's portfolio in Q2 2026, its #864 holding.
Xponance first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.